Insights from 2023 ASCO® Annual Meeting


 

ASCO® 2023 Insights: "Phase I Dose-Escalation Results of PSMA-TRT With Alpha-Radiolabeled Antibody 225Ac-J591 and Beta-Radioligand 177Lu-PSMA I&T"

165 views
June 8, 2023
Comments 0
Login to view comments. Click here to Login